Details for Patent: 8,900,638
✉ Email this page to a colleague
Which drugs does patent 8,900,638 protect, and when does it expire?
Patent 8,900,638 protects KAZANO and is included in one NDA.
This patent has thirty-two patent family members in twenty-six countries.
Summary for Patent: 8,900,638
| Title: | Solid preparation comprising alogliptin and metformin hydrochloride |
| Abstract: | The present invention provides a solid preparation containing compound (I) [compound (I) is as defined in the specification] or a salt thereof, and metformin hydrochloride, which is useful as a therapeutic drug for diabetes and the like, and superior in the preservation stability. A solid preparation having a first part and a second part: a first part: a part containing compound (I) or a salt thereof and substantially free of metformin hydrochloride a second part: a part containing metformin hydrochloride and substantially free of compound (I) and a salt thereof. |
| Inventor(s): | Yamamoto; Kazumichi (Osaka, JP), Koyama; Hiroyoshi (Osaka, JP) |
| Assignee: | Takeda Pharmaceutical Company Limited (Osaka, JP) |
| Application Number: | 12/452,705 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,900,638 |
|
Patent Claim Types: see list of patent claims | Compound; Dosage form; Formulation; Use; |
Drugs Protected by US Patent 8,900,638
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Takeda Pharms Usa | KAZANO | alogliptin benzoate; metformin hydrochloride | TABLET;ORAL | 203414-002 | Jan 25, 2013 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Takeda Pharms Usa | KAZANO | alogliptin benzoate; metformin hydrochloride | TABLET;ORAL | 203414-001 | Jan 25, 2013 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,900,638
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Japan | 2007-188574 | Jul 19, 2007 |
| PCT Information | |||
| PCT Filed | July 16, 2008 | PCT Application Number: | PCT/JP2008/063228 |
| PCT Publication Date: | January 22, 2009 | PCT Publication Number: | WO2009/011451 |
International Family Members for US Patent 8,900,638
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 067557 | ⤷ Try a Trial | |||
| Australia | 2008276842 | ⤷ Try a Trial | |||
| Brazil | PI0814299 | ⤷ Try a Trial | |||
| Canada | 2694620 | ⤷ Try a Trial | |||
| China | 101801351 | ⤷ Try a Trial | |||
| Colombia | 6160301 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
